Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) - Cash on Hand
Cash on Hand as of December 2023 : $56.33 M
According to Curis's latest financial reports the company has $56.33 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Curis - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $56.33 M | -34.21% |
| 2022-12-31 | $85.62 M | -26.11% |
| 2021-12-31 | $0.11 B | -31.22% |
| 2020-12-31 | $0.16 B | 720.2% |
| 2019-12-31 | $20.54 M | -15.36% |
| 2018-12-31 | $24.27 M | -59.71% |
| 2017-12-31 | $60.23 M | 35.4% |
| 2016-12-31 | $44.48 M | -45.88% |
| 2015-12-31 | $82.19 M | 65.21% |
| 2014-12-31 | $49.75 M | -14.49% |
| 2013-12-31 | $58.17 M | 4.75% |
| 2012-12-31 | $55.53 M | 47.25% |
| 2011-12-31 | $37.71 M | -7.1% |
| 2010-12-31 | $40.59 M | 60.78% |
| 2009-12-31 | $25.25 M | -12.48% |
| 2008-12-31 | $28.85 M | -30.41% |
| 2007-12-31 | $41.45 M | 13.1% |
| 2006-12-31 | $36.65 M | -17.09% |
| 2005-12-31 | $44.2 M | -10.71% |
| 2004-12-31 | $49.51 M | 40.11% |
| 2003-12-31 | $35.33 M | -13.76% |
| 2002-12-31 | $40.97 M | -21.36% |
| 2001-12-31 | $52.1 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 22,426.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 21,698.56% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | -0.35% | 🇺🇸 USA |
 Exelixis EXEL | $0.99 B | 1,666.79% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | 651.94% | 🇺🇸 USA |
 Cel-Sci
CVM | $3.24 M | -94.25% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.11 B | 98.28% | 🇺🇸 USA |